In a recent review published in Gene Therapy, a group of authors explored the progress and persistent hurdles in gene therapy for inherited blood disorders, malignancies via chimeric antigen receptors (CAR)-T cells, and varied diseases treated with in vivo adeno-associated virus (AAV) vectors, addressing the transformative cures and the economic and manufacturing complexities involved. Study: … Read more
In a recent review published in the journal Science of The Total Environment, researchers collate and discuss available literature on per- and polyfluoroalkyl substances (PFAS). They highlight PFAS sources in the environment, compare PFAS exposure risk amongst different age groups, and elucidate epidemiological studies on these substances’ hepatotoxicity in vitro and in vivo. They finally … Read more
Wilmington, Delaware, United States, Aug. 28, 2023 (GLOBE NEWSWIRE) — Transparency Market Research Inc. – The global toxicology drug testing market is projected to flourish at a CAGR of 5.5% from 2023 to 2031. As per the report published by TMR, a valuation of US$ 55.9 billion is anticipated for the market in 2031. As … Read more
A change in just one letter in the code that makes up a cancer-causing gene can significantly affect how aggressive a tumor is or how well a patient with cancer responds to a particular therapy. A new, very precise gene-editing tool created by Weill Cornell Medicine investigators will enable scientists to study the impact of … Read more